Heron Therapeutics' combo drug for post-surgical pain wins FDA nod on third try
Heron Therapeutics’ combo drug for post-surgical pain wins FDA nod on third try Heron Therapeutics’ combo drug for post-surgical pain wins FDA nod on third try Heron Therapeutics is positioning its drug, Zynrelef, as a way to help patients avoid addictive opioid painkillers following surgery. The extended-release formulation offers analgesic effects over 72 hours—when postsurgical pain is most severe and more likely to require pain management medication. Shares0 The FDA has approved a Heron Therapeutics combination drug developed to treat postsurgical pain and help patients avoid th...
Source: medcitynews.com